126 related articles for article (PubMed ID: 38679040)
1. Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case-control study.
Saukkoriipi A; Silmon de Monerri NC; Toropainen M; Lindholm L; Veijola R; Toppari J; Knip M; Radley D; Gomme E; Jongihlati B; Anderson AS; Palmu AA; Simon R
Lancet Microbe; 2024 Jul; 5(7):689-696. PubMed ID: 38679040
[TBL] [Abstract][Full Text] [Related]
2. Potential for Maternally Administered Vaccine for Infant Group B Streptococcus.
Madhi SA; Anderson AS; Absalon J; Radley D; Simon R; Jongihlati B; Strehlau R; van Niekerk AM; Izu A; Naidoo N; Kwatra G; Ramsamy Y; Said M; Jones S; Jose L; Fairlie L; Barnabas SL; Newton R; Munson S; Jefferies Z; Pavliakova D; Silmon de Monerri NC; Gomme E; Perez JL; Scott DA; Gruber WC; Jansen KU
N Engl J Med; 2023 Jul; 389(3):215-227. PubMed ID: 37467497
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.
Absalon J; Segall N; Block SL; Center KJ; Scully IL; Giardina PC; Peterson J; Watson WJ; Gruber WC; Jansen KU; Peng Y; Munson S; Pavliakova D; Scott DA; Anderson AS
Lancet Infect Dis; 2021 Feb; 21(2):263-274. PubMed ID: 32891191
[TBL] [Abstract][Full Text] [Related]
4. Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study.
Madhi SA; Izu A; Kwatra G; Jones S; Dangor Z; Wadula J; Moultrie A; Adam Y; Pu W; Henry O; Briner C; Cutland CL
Clin Infect Dis; 2021 Sep; 73(5):e1170-e1180. PubMed ID: 33341870
[TBL] [Abstract][Full Text] [Related]
5. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants.
Dangor Z; Kwatra G; Izu A; Adrian P; Cutland CL; Velaphi S; Ballot D; Reubenson G; Zell ER; Lala SG; Madhi SA
Vaccine; 2015 Nov; 33(48):6793-9. PubMed ID: 26478200
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
[TBL] [Abstract][Full Text] [Related]
7. A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.
Buurman ET; Timofeyeva Y; Gu J; Kim JH; Kodali S; Liu Y; Mininni T; Moghazeh S; Pavliakova D; Singer C; Singh S; Handke LD; Lotvin J; Prasad AK; Scully IL; Donald RGK; Jansen KU; Anderson AS
J Infect Dis; 2019 Jun; 220(1):105-115. PubMed ID: 30778554
[TBL] [Abstract][Full Text] [Related]
8. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
[TBL] [Abstract][Full Text] [Related]
9. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
[TBL] [Abstract][Full Text] [Related]
10. Infant serotype specific anti-capsular immunoglobulin G antibody and risk of invasive group B Streptococcal disease.
Dangor Z; Kwatra G; Izu A; Khan M; Lala SG; Madhi SA
Vaccine; 2021 Nov; 39(47):6813-6816. PubMed ID: 34688499
[TBL] [Abstract][Full Text] [Related]
11. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
12. A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.
Hillier SL; Ferrieri P; Edwards MS; Ewell M; Ferris D; Fine P; Carey V; Meyn L; Hoagland D; Kasper DL; Paoletti LC; Hill H; Baker CJ
Clin Infect Dis; 2019 May; 68(12):2079-2086. PubMed ID: 30281066
[TBL] [Abstract][Full Text] [Related]
13. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
[TBL] [Abstract][Full Text] [Related]
14. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants.
Dangor Z; Kwatra G; Izu A; Lala SG; Madhi SA
Expert Rev Vaccines; 2015 Jan; 14(1):135-49. PubMed ID: 25242617
[TBL] [Abstract][Full Text] [Related]
15. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
[TBL] [Abstract][Full Text] [Related]
16. Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study.
Karampatsas K; Hall T; Voysey M; Carreras-Abad C; Cochet M; Ramkhelawon L; Peregrine E; Andrews N; Heath PT; Le Doare K
Vaccine; 2024 May; 42(13):3230-3238. PubMed ID: 38627147
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Breast Milk Group B Streptococcal Capsular Antibody Levels and Late-onset Disease in Young Infants.
Dangor Z; Khan M; Kwatra G; Izu A; Nakwa F; Ramdin T; Fredericks J; Lala SG; Madhi SA
Clin Infect Dis; 2020 Mar; 70(6):1110-1114. PubMed ID: 31056692
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines.
Dzanibe S; Madhi SA
Expert Rev Vaccines; 2018 Jul; 17(7):635-651. PubMed ID: 29961350
[TBL] [Abstract][Full Text] [Related]
19. Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.
Madhi SA; Koen A; Cutland CL; Jose L; Govender N; Wittke F; Olugbosi M; Sobanjo-Ter Meulen A; Baker S; Dull PM; Narasimhan V; Slobod K
Clin Infect Dis; 2017 Nov; 65(11):1897-1904. PubMed ID: 29029127
[TBL] [Abstract][Full Text] [Related]
20. Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.
Yang HH; Mascuch SJ; Madoff LC; Paoletti LC
Clin Vaccine Immunol; 2008 Jul; 15(7):1035-41. PubMed ID: 18463225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
